Actively Recruiting
Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
Led by European Institute of Oncology · Updated on 2024-03-20
120
Participants Needed
1
Research Sites
454 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this observational prospective studi patients with invasive breast cancer no more than 5 cm and clinically node negative, scheduled for conservative surgery and Sentinel Node Biopsy (SNB), are enrolled in the protocol if they have 1-2 sentinel lymphnodes (SLNs) with macrometastases. SLN status will be checked on definitive sections.
CONDITIONS
Official Title
Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically proven invasive breast cancer
- Breast conserving surgery without axillary dissection
- Tumor size no more than 5 cm
- No more than 2 positive sentinel lymph nodes
- Negative surgical margin (no tumor cells on ink)
- Performance status less than 2
- Age over 18 years
- Written informed consent provided
You will not qualify if you...
- Previous thoracic radiotherapy
- Mixed connective tissue disorders
- Presence of distant metastases
- Severe lung or heart diseases
- Prior neoadjuvant systemic therapies
- Axillary dissection performed
- No surgical axillary investigation done
- Mastectomy performed
- Presence of axillary micrometastasis or isolated tumor cells
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
European Institute of Oncology
Milan, Italy
Actively Recruiting
Research Team
M
Maria Cristina Leonardi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here